CA-DIVERSIFIED-NANO
28.9.2018 14:52:06 CEST | Business Wire | Press release
Diversified Nano Solutions Corp launches revolutionary smartINK™ solutions to deliver the next generation of functional security printing to brand owners in any industry, institutions and individuals.
For the first time functional content printing and total security are delivered simultaneously and cost effectively by integrating copy-proof, unique and customer-specific smartQR™ biomarkers (watch video ) with the whole spectrum of digital inks.
Breakthrough smartINK ™ provides print and instant product identity and location tracking, at unbelievably low cost, on-the-spot, anywhere, anytime, by anyone.
Counterfeiting and illicit trade are pervasive in nearly every industry sector, harming consumers and brand owners, while costing the global economy over 1 trillion dollars annually.
Preservation of product and information integrity is increasingly important as sophisticated counterfeiting efforts easily defeat existing anti-counterfeit technologies.
smartINK™ makes it fun and easy to verify item integrity while establishing trust and defending item value. The smartINK™ solution scales easily, so individual brand owners and large enterprises alike can grow market share and successfully eliminate illicit trade and counterfeiting. Unbelievably low implementation costs enable fast payback and rapid deployment of secure mobile authentication and tracking worldwide.
As an expansion beyond digital print, DNSC is powering INKcrypt® smartQR™ available at www.goinkcrypt.com . FDA-compliant INKcrypt® smartQR™ enables tagging and marking of any physical object with traces of custom biomarkers using a variety of methods – including spray, brush, roll, flexo, offset and more.
Contact https://inkcryptink.com/ContactUs.aspx for details and to coordinate implementation of your smartINK™ and INKcrypt® smartQR™ solution.
smartINK™ solutions are compatible with inkjet platforms offered by Canon®, Screen®, Epson®, Ricoh®, HP®, FujiFilm®, Xerox®, Kyocera®, Konica Minolta® and more. Visit booth 829 at PRINT 18 September 30-October 2, 2018, in Chicago.
About DNSC
Diversified Nano Solutions Corporation (DNSC) , based in San Diego, California, specializes in developing, manufacturing and marketing high-performance inkjet inks and revolutionary, industry-unique smartINK™ solutions. Utilizing customer-specific INKcrypt® xDNA biomarker technology, smartINK™ provides total product & document security, proof of identity and worldwide tracking, anytime anywhere, at incredibly low cost. smartINK™ combines INKcrypt® xDNA™ biomarkers, the power of the internet and DNSC’s extensive product line of inks including CMYK , MICR (Magnetic Ink Character Recognition), invisible UV fluorescent / IR absorbing , spot and custom formulations .
Accessories and Security
DNSC supports its ink offerings with accessories to facilitate and aid x-nano™ ink use and smartINK™ solutions. These include specialty substrates, smartQR™ biomarker authentication testers, UV display lights, INKVERSE ™ “Infinite Ink Infuser” – a revolutionary and cost-effective way to adopt and deliver digital inks to existing and new inkjet systems via a continuous delivery ink supply system, and TransChrome ™ – an invisible color image generator to transform visible CMYK into invisible UV fluorescent red, green, blue, and white (RGBW) output, and more.
DNSC is presenting smartINK™ solutions, INKcrypt® smartQR™ and its line of black & color, magnetic, invisible, special effect, and security inks for the world’s leading inkjet print systems in the desktop, commercial and industrial inkjet space.
Visit us at booth 829 and discover the future of digital ink: functional, secure, trackable, differentiating!
View source version on businesswire.com: https://www.businesswire.com/news/home/20180928005061/en/
Contact:
For more information: Diversified Nano Solutions Corporation Linda Meyers US Headquarters: +1.858.924.1005 EMEA: +41.41 874 08 50 info@diversifiednano.com www.diversifiednano.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Redslim expands into Asia-Pacific to support global brands with data and AI infrastructure12.3.2026 07:00:00 CET | Press release
Redslim, a specialist in end-to-end data management solutions and an Astorg portfolio company, today announced its expansion into the Asia-Pacific region and the appointment of Kyriakos Zannikos as Regional Director, APAC. The move marks an important milestone in Redslim’s global growth strategy and brings the company closer to clients operating in one of the world’s fastest-growing and most data-driven consumer markets. As global consumer brands accelerate digital transformation and AI adoption, many organizations still struggle with fragmented data ecosystems spanning multiple agencies, markets and datasets. These challenges are particularly pronounced in Asia-Pacific, where diverse market structures and rapid growth create complex data environments. Redslim helps organizations transform fragmented market information into valuable data assets, empowering clients to make confident decisions and unlock the full value of their data. By building strong data foundations, Redslim supports
Meiji Seika Pharma Initiates Phase I Clinical Trial in Australia Evaluating ME3241, an Anti-PD-1 Agonist Antibody Discovered Through Collaborative Research With FBRI12.3.2026 07:00:00 CET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) announced today that it has initiated a Phase I clinical trial of ME3241 (development code), an anti-PD-1 agonist monoclonal antibody discovered through collaborative research with the Foundation for Biomedical Research and Innovation at Kobe (Headquarters: Kobe, Japan; President: Shuh Narumiya; hereinafter “FBRI”). The Phase I clinical trial is designed as a randomized, placebo-controlled, double-blind study, with the objective of evaluating the safety and tolerability of ME3241 following single and multiple dosing, as well as its pharmacokinetics and pharmacodynamics (ClinicalTrials.gov: NCT07422207). ME3241 was discovered through a collaborative research program led by Program Director Tasuku Honjo, a professor emeritus at Kyoto University. PD-1 is a molecule expressed on activated T cells and other lymphocytes that suppresses immune responses. Through this re
Andersen Consulting styrker sin platform med samarbejdsvirksomheden Ambit Iberia12.3.2026 05:55:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med Ambit Iberia, et konsulentfirma, der specialiserer sig i digitale og regulatoriske løsninger til life science-sektoren. Ambit Iberia, der blev stiftet i 2003, har hovedsæde i Spanien og leverer integrerede løsninger inden for rådgivning, teknologi og rekruttering til medicinal-, bioteknologi- og medtechvirksomheder. Virksomheden hjælper kunder med at opfylde skiftende standarder for kvalitet, compliance og lovgivning gennem ydelser, der spænder over regulatoriske anliggender, dataintegritet, validering af it-systemer og digital transformation. Med mere end 20 års brancheerfaring tilbyder Ambit Iberia også ydelser inden for human capital og executive search, der forbinder organisationer med specialiserede fagfolk og topledertalenter, hvilket øger effektiviteten og fremmer bæredygtig vækst i et stærkt reguleret miljø. "Vores fokus har altid været at levere speciali
EIG’s MidOcean Energy to Acquire Additional Gorgon LNG Interest from JERA; Parties Explore Strategic Alliance12.3.2026 03:14:00 CET | Press release
Transaction increases MidOcean’s equity exposure to premier Australian LNG project Adds incremental uncontracted LNG volumes, enhancing portfolio optimization and marketing flexibility Planning future collaborations, exploring further transactions and opportunities with JERA across other assets globally with the aim of creating a future strategic alliance MidOcean Energy (“MidOcean”), a liquefied natural gas (LNG) company formed and managed by EIG, today announced it has entered into definitive agreements with JERA Co., Inc. (“JERA”) to acquire JERA Gorgon Pty Ltd, which holds JERA’s 0.417% interest in the Gorgon LNG project. MidOcean is an existing participant in the Gorgon LNG project, and this transaction increases MidOcean’s interest in Gorgon to 1.417%. The transaction perimeter also includes JERA’s 0.735% interest in the Ichthys LNG project. Subject to the satisfaction of relevant conditions precedent, the interests in Gorgon and Ichthys will be sold to MidOcean, and then the Ich
DCX Launches Comprehensive ECDU Portfolio – Enterprise-Class Coolant Distribution Units From 600 kW to 2.6 MW11.3.2026 16:34:00 CET | Press release
DCX Liquid Cooling Systems today unveiled its new ECDU (Enterprise Coolant Distribution Unit) platform, a family of three purpose-built CDU models that deliver real cooling capacities from 600 kW to 2.6 MW in industry-standard rack and in-row footprints. The portfolio has been engineered specifically for the accelerating transition to direct-to-chip liquid cooling in high-density enterprise, colocation, cloud, and hyperscale AI environments where thermal stability, uptime, and cost-efficiency are non-negotiable. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260311214891/en/ DCX ECDU, the new generation of Enterprise Coolant Distribution Units dedicated to HPC and AI deployments. The lineup consists of: Enterprise ECDU 1380/2600 V1 - Delivers 1.38–2.6 MW of actual cooling capacity (based on real-world secondary-loop conditions). Single-pump configuration reaches flow rates up to 3,333 liters per minute (lpm). Mission Critica
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom